PureTech Health plc - American Depositary Shares — Balance Sheet (NASDAQ:PRTC) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 989.99 M946.01 M702.65 M693.97 M602.63 M534.71 M Total liabilities 336.45 M361.86 M155.06 M235.74 M194.7 M229.03 M Total equity 653.54 M584.15 M547.59 M458.23 M407.93 M305.68 M Total liabilities & shareholders' equities 989.99 M946.01 M702.65 M693.97 M602.63 M534.71 M Total debt —————— Net debt ——————

PureTech Health plc - American Depositary Shares

PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange.

News

Deupirfenidone receives orphan drug status for rare lung disease

PureTech’s deupirfenidone receives FDA and EU orphan drug status for IPF

PureTech Health plc (PRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

PureTech CEO to present at J.P. Morgan Healthcare Conference

PureTech Health appoints Robert Lyne as permanent CEO

PureTech provides update on AGM results following shareholder concerns

PureTech stock falls after FDA meeting on IPF drug

Meihua International Medical Technologies, Fly-E Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Arteris (NASDAQ:AIP), Chagee Holdings (NASDAQ:CHA)

FDA supports PureTech’s deupirfenidone for IPF to advance to phase 3

Gallop’s leukemia drug shows promising survival in late-stage trial

PureTech’s Gallop reports promising AML treatment data

LYT-200 shows promising results in relapsed/refractory AML patients